Skip to content

Drug interactions

Crizotinib + Dichlorphenamide

Severity: Moderate

Crizotinib and Dichlorphenamide: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Dichlorphenamide causes potassium loss, and crizotinib can prolong the QT interval and cause bradycardia. Hypokalemia increases the risk of QT-related arrhythmias.

What this interaction means in plain words

Crizotinib and Dichlorphenamide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Crizotinib belongs to Oncology; Dichlorphenamide belongs to Miscellaneous.

Evidence level: Low

Why it happens

Dichlorphenamide-induced hypokalemia increases proarrhythmic risk of crizotinib's QT prolongation.

What to do

Monitor serum potassium and ECG, and replace potassium to keep levels in the normal range.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Crizotinib and Dichlorphenamide, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Crizotinib with Dichlorphenamide?

MediHelp rates the interaction as moderate. Crizotinib and Dichlorphenamide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Dichlorphenamide causes potassium loss, and crizotinib can prolong the QT interval and cause bradycardia. Hypokalemia increases the risk of QT-related arrhythmias.

How serious is the interaction between Crizotinib and Dichlorphenamide?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor serum potassium and ECG, and replace potassium to keep levels in the normal range.

What other medicines interact with Crizotinib?

MediHelp also lists interactions of Crizotinib with, for example, Flibanserin, Lomitapide, Lonafarnib. The full list is on the Crizotinib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in